No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas

Diabetes Care. 2003 Nov;26(11):3191-2. doi: 10.2337/diacare.26.11.3191-a.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • DNA-Binding Proteins / genetics*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / genetics
  • Hepatocyte Nuclear Factor 1
  • Hepatocyte Nuclear Factor 1-alpha
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*
  • Middle Aged
  • Nuclear Proteins / genetics*
  • Sulfonylurea Compounds / therapeutic use*
  • Transcription Factors / genetics*

Substances

  • DNA-Binding Proteins
  • HNF1A protein, human
  • Hepatocyte Nuclear Factor 1-alpha
  • Hypoglycemic Agents
  • Insulin
  • Nuclear Proteins
  • Sulfonylurea Compounds
  • Transcription Factors
  • Hepatocyte Nuclear Factor 1